netFormulary Northern Lincolnshire NHS
Formulary  
 Search
 Formulary Chapter 1: Gastro-intestinal system - Full Section
Notes:

The Constipation Pathway can be viewed here

http://www.northernlincolnshireapc.nhs.uk/wp-content/uploads/2018/05/updated-FINAL-Constipation-Pathway-V1.3-tidied-diagram-and-added-opioid-induced-assessment-3.pdf

 

The Stoma Care Appliances Guideline can be viewed here

http://www.northernlincolnshireapc.nhs.uk/wp-content/uploads/2018/08/stoma-care-Northern-Lincolnshire-Area-prescribing-Committee-Guidelines-for-the-Prescribing-v1-20180614.pdf

 

Continence Formulary ( NEL) can be vie here :

http://www.northernlincolnshireapc.nhs.uk/wp-content/uploads/2018/10/MOPP-024-V1-Continence-Formulary-NEL-2.pdf

 

Numbers in brackets indicate counts of (Formulary items, Non Formulary items)
01.01 Dyspepsia and gastro-oesophageal reflux disease (0,2)
Dyspepsia (0,0)
Gastro-oesophageal reflux disease (0,0)
01.01.01 Antacids and simeticone (0,0)
Aluminium and magnesium containing antacids (3,0)
Aluminium-magnesium complexes (0,0)
Antacid preparations containing simeticone (2,0)
Simeticine alone (0,2)
Antacid preparations containing dimeticone or local anaesthetics (0,0)
01.01.02 Compound alginates and proprietary indigestion preparations (0,0)
Compound alginate preparations (4,0)
01.02 Antispasmodics and other drugs altering gut motility (0,0)
Antimuscarinics (2,1)
Other antispasmodics (2,1)
Motility stimulants (0,0)
01.03 Antisecretory drugs and mucosal protectants (0,0)
Helicobacter pylori infection (0,4)
NSAID-associated ulcers (0,0)
01.03.01 H2-receptor antagonists (2,0)
01.03.02 Selective antimuscarinics (0,0)
01.03.03 Chelates and complexes (2,0)
01.03.04 Prostaglandin analogues (1,0)
01.03.05 Proton pump inhibitors (PPIs) (5,0)
01.03.06 Other ulcer-healing drugs (0,0)
01.04 Acute diarrhoea (0,0)
01.04.01 Adsorbents and bulk-forming drugs (0,0)
01.04.02 Antimotility drugs (3,0)
01.04.03 Enkephalinase Inhibitors (0,0)
01.05 Chronic bowel disorders (0,0)
Irritable bowel syndrome (0,0)
Malabsorption syndromes (0,0)
Inflammatory bowel disease (0,0)
Antibiotic-associated colitis (0,0)
Diverticular disease (0,0)
Aminosalicylates (0,0)
Corticosteroids (0,0)
Food allergy (0,0)
Cytokine inhibitors (0,0)
Food Allergy (0,0)
01.05.01 Aminosalicylates (8,1)
01.05.02 Corticosteroids (4,1)
Oral (0,0)
01.05.03 Drugs affecting the immune response (5,0)
Cytokine inhibitors : Treatment of ulcerative colitis and Crohn’s diseaseTwo biosimilar versions of (5,0)
01.05.04 Food allergy (1,0)
01.06 Laxatives (0,0)
01.06.01 Bulk-forming laxatives (2,0)
01.06.02 Stimulant laxatives (6,0)
Other Stimulant laxatives (0,0)
01.06.03 Faecal softeners (1,0)
01.06.04 Osmotic laxatives (3,0)
01.06.05 Bowel cleansing preparations (6,2)
01.06.06 Peripheral opioid-receptor antagonist (2,0)
01.06.07 Other drugs used in constipation (3,0)
01.07 Local preparations for anal and rectal disorders (0,0)
01.07.01 Soothing haemorrhoidal preparations (1,1)
01.07.02 Compound haemorrhoidal preparations with corticosteroids (4,1)
01.07.03 Rectal sclerosants (1,0)
01.07.04 Management of anal fissures (2,0)
01.08 Stoma care (0,0)
01.09 Drugs affecting intestinal secretions (0,0)
01.09.01 Drugs affecting biliary composition and flow (2,0)
Other prepatations for biliary disorders (0,0)
01.09.02 Bile acid sequestrants (2,0)
01.09.03 Aprotinin (0,0)
01.09.04 Pancreatin (3,1)
01.10 New Sub Section (0,0)
netFormulary